RNA 5-methylcytosine (m5C) is a widespread modification and plays a crucial role in gene expression regulation. Here, we present a protocol for transcriptome-wide m5C methylome profiling at base resolution using bisulfite-free m5C detection strategy enabled by ten-eleven translocation (TET)-assisted chemical labeling sequencing (m5C-TAC-seq). We detail steps for TET-assisted chemical labeling, library construction, and data analysis. m5C-TAC-seq enables accurate and robust m5C detection in various RNA species. For complete details on the use and execution of this protocol, please refer to Lu et al.1.
SUMMARY: N6 -methyladenosine (m 6 A), the most abundant internal mRNA modification, and N6 ,2’-O-dimethyladenosine (m 6 Am), found at the first-transcribed nucleotide, are two examples of dynamic and reversible epitranscriptomic marks. However, the profiles and distribution patterns of m 6 A and m 6 Am across different human and mouse tissues are poorly characterized. Here we report the m 6 A and m 6 Am methylome through an extensive profiling of 42 human tissues and 16 mouse tissue samples. Globally, the m 6 A and m 6 Am peaks in non-brain tissues demonstrates mild tissue-specificity but are correlated in general, whereas the m 6 A and m 6 Am methylomes of brain tissues are clearly resolved from the non-brain tissues. Nevertheless, we identified a small subset of tissue-specific m 6 A peaks that can readily classify the tissue types. The number of m 6 A and m 6 Am peaks are partially correlated with the expression levels of their writers and erasers. In addition, the m 6 A- and m 6 Am-containing regions are enriched for single nucleotide polymorphisms. Furthermore, cross-species analysis of m 6 A and m 6 Am methylomes revealed that species, rather than tissue types, is the primary determinant of methylation. Collectively, our study provides an in-depth resource for dissecting the landscape and regulation of the m 6 A and m 6 Am epitranscriptomic marks across mammalian tissues.